Uterine Closure at C-section by Stratafix Tissue Control Device: Randomized Case-Control Study
1 other identifier
interventional
100
1 country
1
Brief Summary
Comparative study of the surgical outcome of 2-layers closure technique of uterine incision in Cesarean section using bidirectional barbed suture (Stratafix) and conventional suture material (Vicryl) regarding the time of closure and the need of secondary additional suturing or tearing of uterine muscles during suturing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 5, 2014
CompletedFirst Posted
Study publicly available on registry
November 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedJanuary 27, 2016
January 1, 2016
1.2 years
November 5, 2014
January 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time needed to close the uterine incision
A model is set to evaluate success and failure according the ime needed to close the uterine incision if more or less than 6 minutes
6 minutes
Secondary Outcomes (1)
blood loss during uterine closure
intraoperative during uterine closure
Other Outcomes (1)
Duration of hospital stay
Six weeks following the cesarean delivery (completion of the postpartum period)
Study Arms (2)
Stratafix Tissue control device
OTHERClosure of Uterine incision at C section
Vicryl suture
OTHERClosure of uterine incision at C section
Interventions
Closure of uterine incision at Cesarean section
Eligibility Criteria
You may qualify if:
- All pregnant patients with an indication for delivery by C section
You may not qualify if:
- Patient refusing to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mohamed Zayedlead
- Cairo Universitycollaborator
- Johnson & Johnson Medical Companiescollaborator
Study Sites (1)
Faculty of Medicine Cairo University
Cairo, Cairo Governorate, 11559, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Z Ahmed, MD PhD
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Obstetrics and Gynecology Cairo University
Study Record Dates
First Submitted
November 5, 2014
First Posted
November 11, 2014
Study Start
October 1, 2013
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
January 27, 2016
Record last verified: 2016-01